Sharma, R.; Singh, S.; Whiting, Z.M.; Molitor, M.; Vernall, A.J.; Grimsey, N.L.
Novel Cannabinoid Receptor 2 (CB2) Low Lipophilicity Agonists Produce Distinct cAMP and Arrestin Signalling Kinetics without Bias. Int. J. Mol. Sci. 2023, 24, 6406.
https://doi.org/10.3390/ijms24076406
AMA Style
Sharma R, Singh S, Whiting ZM, Molitor M, Vernall AJ, Grimsey NL.
Novel Cannabinoid Receptor 2 (CB2) Low Lipophilicity Agonists Produce Distinct cAMP and Arrestin Signalling Kinetics without Bias. International Journal of Molecular Sciences. 2023; 24(7):6406.
https://doi.org/10.3390/ijms24076406
Chicago/Turabian Style
Sharma, Raahul, Sameek Singh, Zak M. Whiting, Maximilian Molitor, Andrea J. Vernall, and Natasha L. Grimsey.
2023. "Novel Cannabinoid Receptor 2 (CB2) Low Lipophilicity Agonists Produce Distinct cAMP and Arrestin Signalling Kinetics without Bias" International Journal of Molecular Sciences 24, no. 7: 6406.
https://doi.org/10.3390/ijms24076406
APA Style
Sharma, R., Singh, S., Whiting, Z. M., Molitor, M., Vernall, A. J., & Grimsey, N. L.
(2023). Novel Cannabinoid Receptor 2 (CB2) Low Lipophilicity Agonists Produce Distinct cAMP and Arrestin Signalling Kinetics without Bias. International Journal of Molecular Sciences, 24(7), 6406.
https://doi.org/10.3390/ijms24076406